FDW8 schreef op 14 mei 2021 09:16:
May 13, 2021, 9:15 PM EDTSHARE ON:
Oppenheimer analyst Hartaj Singh maintained a Buy rating on Pharming Group (PHAR) yesterday and set a price target of
$43.00. The company’s shares closed last Thursday at $11.91.
According to TipRanks.com, Singh is a 4-star analyst with an average return of 13.1% and a 44.5% success rate. Singh covers the Healthcare sector, focusing on stocks such as Opthea Limited Sponsored ADR, Catabasis Pharmaceuticals, and Alexion Pharmaceuticals.
Currently, the analyst consensus on Pharming Group is a Moderate Buy with an average price target of $43.00.